Subscribe to Newsletter
Manufacture Advanced Medicine, Trends & Forecasts

Oligonucleotide therapeutics: manufacturing for research and beyond

sponsored by Cytiva

View On-Demand

It’s time for oligonucleotide therapeutics to step into the light. With an increase in therapies in preclinical and clinical stages, many therapeutic developers find that they need to scale up quickly to meet demand. 

Considering manufacturability and scale-up during small-scale method development will help deliver process efficiency and scalability, ensuring smooth technology transfer and saving time and materials. In this presentation, we’ll discuss strategies to future-proof your manufacturing for vaccines, therapeutics, and more.

Webinar Learning Objectives:

  • An overview of the current clinical landscape for oligo therapeutics
  • Key considerations for starting in-house oligonucleotide synthesis
  • Considerations for clinical scale-up

View On-Demand

Receive content, products, events as well as relevant industry updates from The Medicine Maker and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine